Washington University School of Medicine, Site 007 — St Louis, Missouri

Washington University School of Medicine, Site 007 is a clinical research site located in St Louis, Missouri, United States 63110.

Crixeo Health Trust Score: 44/100 (POOR). This profile has not yet been claimed by the site owner.

Washington University School of Medicine, Site 007 has participated in 1 clinical trials.

Therapeutic areas: Chronic Myeloid Leukemia (CML), Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL).

Sponsors: Ariad Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 44/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Washington University School of Medicine, Site 007?

Washington University School of Medicine, Site 007 has a Crixeo Trust Score of 44/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Washington University School of Medicine, Site 007 conducted?

Washington University School of Medicine, Site 007 has 1 clinical trials on record. Their work covers Chronic Myeloid Leukemia (CML), Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL).

Is Washington University School of Medicine, Site 007 accredited by Crixeo Health?

Washington University School of Medicine, Site 007 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Washington University School of Medicine, Site 007?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.